protein could cross cell membranes and transactivate Manipulation of mammalian cells has been achieved by the a viral genome. In 1994, Fawell et al. (3) expanded on transfection of expression vectors, microinjection, or diffusion of this observation by demonstrating that heterologous peptidyl mimetics. While these approaches have been somewhat proteins chemically crosslinked to a 36-amino-acid dosuccessful, the classic manipulation methods are not easily regumain of Tat were able to transduce into cells. While lated and can be laborious. One approach to circumvent these problems is the use of HIV TAT-mediated protein transduction. applicability of the Tat fusions was demonstrated by Although this technology was originally described in 1988, few the chemical crosslinking of a 36-amino-acid domain improvements were reported in the subsequent 10 years. In the of HIV Tat to a protein of choice (3), its widespread last few years, significant steps have been taken to advance this application could not be realized.
and are therefore not easily isolated by standard aque-must be weighed heavily in the safety of the transduction process. If the protein one wishes to transduce is ous methods. Sonication of the bacterial pellets in urea known to be toxic or pro-apoptotic, then the TAT-fusion disaggregates the insoluble proteins, allowing for their version will likely be more so. We recommend following enrichment and preparation into a usable, soluble form.
NIH Biosafety Level (BSL) 2 guidelines for the The second goal is to prepare denatured proteins, which safe handling of recombinant proteins. These safety have a higher potential for biological effect than their guidelines can be accessed via the worldwide web counterparts prepared under soluble conditions (7) . We at the following web site: http://bmbl.od.nih.gov/ hypothesized that, due to reduced structural consect3bsl2.htm for BSL2. straints, higher-energy (⌬G), denatured proteins may General safety precautions should be taken when protransduce more efficiently into cells than lower-energy, ducing TAT-fusion proteins: correctly folded ones. Once inside the cell, transduced, denatured proteins, can be correctly refolded by chaper-1. Purified fusion protein should be treated as a lowones (8) such as HSP90 (9) . Indeed, an analysis of TAT-level radionuclide, such as 35 S. Use plastic covered abp27 Kip1 protein revealed that when this protein was sorbent paper on benchtops, latex gloves, safety glasses, urea denatured, the biological phenotypes were en-and a lab coat. hanced dramatically over protein prepared under solu-2. In case of spills involving concentrated protein, ble conditions (7) . However, while preparing TAT-fusion digest the proteins with a solution of 5% Terg-A-Zyme proteins in this manner is advantageous in most situa-(VWR Scientific) at room temperature for approxitions and results in dramatic yield increases, it is mately 10 min. The liquid should be adsorbed with clearly not an obligatory step. damp paper towels and then wiped down again with TAT-Fusion proteins prepared by this method have 70% ethanol. been shown to transduce into a variety of both primary 3. Any glassware containing the bacteria that exand transformed cell types, including peripheral blood press the fusion protein of interest should be decontamilymphocytes (PBLs), diploid human fibroblasts, kera-nated with a solution of 10% bleach, which should then tinocytes, bone marrow stem cells, osteoclasts, fibrosar-be flushed down a sink with running water for at least coma cells, leukemic T cells, osteosarcoma, glioma, he-5 min. patocellular carcinoma, renal carcinoma, NIH 3T3 cells, 4. When sonicating the bacterial pellets, use of a and all cells present in whole blood, including both nu-sonication cabinet is suggested to reduce the risk of cleated and enucleated cells (10-13). Moreover, TAT-aerosolized fusion protein. fusion proteins were shown to transduce into all cells 5. Adhere to local guidelines on the disposal of solid and tissues present in mice, including those present biological waste. across the blood-brain barrier (14, 15) . To date, this strategy has resulted in the production of more than 60 full-length proteins with functional domains from ESSENTIAL COMPONENTS REQUIRED TO 15 to 120 kDa. The fusions span a variety of functional GENERATE TRANSDUCIBLE PROTEINS classes, suggesting that many, if not most, proteins may be transduced into cells using this technology (7, 10- A. Construction of Tat-Fusion cDNA using pTAT/pTAT-16).
HA Plasmids.
Transducible proteins are generated by cloning the
SAFETY CONSIDERATIONS
cDNA of interest into the pTAT or pTAT-HA bacterial expression vector. The pTAT-HA vector contains an am-TAT-Fusion proteins have been shown to cross several picillin resistance marker, for selection after transforbiological barriers such as the blood-brain barrier. mation; a T7 polymerase promoter; an N-terminal 6-They have also been shown to transduce virtually any histidine leader followed by the 11-amino-acid TAT docell type tested in vitro including cells classically main (7), flanked by glycine residues for free bond rotathought untransducible such as bone marrow and osteo-tion; a hemagglutinin (HA) tag; and a polylinker (Fig. clasts. Because of these facts, it is important to consider 1A). The pTAT vector contains the same components the safe handling of the fusion proteins.
with exception of the HA tag. To obtain a genetic NAlthough the TAT transduction domain was origi-terminal in-frame fusion with the TAT leader, the 5Ј nally identified from HIV, no infectious materials are UTRs of the cDNA must be deleted. Cloning into the contained within this domain. The peptide or amino NcoI restriction site and use of this site's ATG as the initiator methionine will yield an in-frame fusion with acid sequence attached to the TAT transduction domain the upstream leader. However, the plasmid was de-rial strain. This strain has been optimized for recombisigned so that use of any of the restriction sites within nant protein expression by using Escherichia coli B that the polylinker, except AgeI, will yield an in-frame fu-naturally lack lon protease and OmpT protease. In a sion. Although the plasmid contains a transcriptional few cases, it may be advantageous to use other BL21 termination sequence, to avoid adding nonspecific C-derivatives such as BL21 CodonPlus (Stratagene, Ceterminal amino acids, use of the stop codon from the dar Creek, TX) which further optimize recombinant cDNA of interest is suggested. The pTAT-HA-cDNA protein expression because extra copies of rare E. coli plasmid is then transformed into a bacterial strain that tRNA genes have been added that overcome codon bias yields a high-copy plasmid number, such as DH5␣ (Life when genomes are AT or GC rich. Six to twelve indepenTechnologies, Gaithersburg, MD). The individual clones dent isolates are grown as 1-ml overnight cultures in can then be isolated and analyzed for the correct insert Luria broth (LB) (Sigma Chemical Co., St. Louis, MO), size by standard molecular biology techniques and fi-with 50 U amp in the presence of 100 M isopropylthinally the DNA sequence can be confirmed by automated ogalactoside (IPTG). DNA sequencing. within lots can vary. Therefore, careful optimization of TAT-fusion proteins, including TAT-Caspase-3, TATprotein production is suggested by comparing LB from pRB, and TAT-Bid, are toxic to log-phase bacterial cells. various lots and manufacturers. We have also found Therefore, we inoculate a 1-liter overnight culture and that in some instances a construct will express poorly isolate the cell pellet immediately in the morning. in LB, but more abundantly in other media such as
The clarified sonicate is equilibrated in 10-20 mM Terrific Broth (TB) (Life Technologies).
imidazole, then applied at room temperature to a prePellet the bacterial suspension and resuspend the equilibrated 3-to 10-ml Ni-NTA (Qiagen, Valencia, CA) pellet fraction in 2ϫ SDS sample buffer, then analyze by packed in an Econo column (Bio-Rad, Hercules, CA) in SDS-PAGE. Load two gels identically with the various Buffer Z plus 10-20 mM imidazole. The low concentraclones plus one with a nonexpressing BL21(DE3)pLysS tion of imidazole at this step is required to reduce the transformed with the empty pTAT/pTAT-HA vector as background contaminating proteins which may nonspea negative control. One gel can then be stained with cifically bind to the Ni-NTA resin. Although 20 mM Coomassie blue to look for an overexpressing protein imidazole is routinely used as a starting point, nonspeband with respect to the nonrecombinant expressing cific binding can sometimes still be observed. If this lysate. Note that not all TAT-fusion proteins are ex-problem persists, increase the imidazole concentration pressed at a substantial enough level to be viewed in up to 30 mM. Allow the column to proceed by gravity this manner. Therefore, the second gel, if required, or apply slight air pressure via syringe as required. should be transferred to a filter and probed with anti-Save some of the start (St) and flow-through (FT) for HA antibody (Berkley Antibody Co., Richmond, CA) or SDS-PAGE analysis. Wash the column with approxiantibodies directed against the cDNA-encoded product mately 10 bed volumes of Buffer Z plus 10-20 mM by immunoblot analyses. Although the TAT leader con-imidazole. Elute the TAT-fusion protein by stepwise adfers a ϳ5-kDa increase in molecular weight, we consis-dition of 1 bed volume of Buffer Z containing 100 mM, tently detect a 5-to 10-kDa increase in size by denatur-250 mM, 500 mM, and 1 M imidazole. Analyze the ing SDS-PAGE. Prepare glycerol stocks of three to five St, FT, and each column fraction by Coomassie blue of the highest expressing BL21(DE3)LysS isolates and staining of an SDS-polyacrylamide gel (Fig. 1B) and choose a single isolate to purify as described below.
immunoblot analysis as outlined above. Pool the appropriate fractions together. For TAT-fusion proteins purified under native condiLarge-Scale Purification of TAT-Fusion Proteins tions, sonicate in PBS or 20 mM Hepes, pH 7.2, 100 We devised a denaturing protocol, using either 8 M mM NaCl, in the presence of protease inhibitors. Apply urea or 6 M guanidine hydrochloride, to purify TAT-to Ni-NTA as outlined above, elute with increasing imfusion proteins to increase both the transduction poten-idazole concentrations, then simply desalt via a PD-10 tial (7) and the yield by recovering all of the recombi-column into the buffer or medium of choice. nant protein present in bacterial inclusion bodies. HowTroubleshooting. If the TAT protein is detected priever, we have recently observed that several proteins marily in the FT, decrease the imidazole concentration produced superior results when purified under native in loading Buffer Z; and if a high background of contamiconditions. In addition, although the protocol was originating bacterial proteins are detected, increase the imnally designed for use with an FPLC (fast protein liquid idazole concentration of the loading buffer. In addition, chromatography) protein purification system, due to due to the "head" binding nature of the Ni-NTA column, the use of single steps to perform buffer changes, comremoving the urea (see below) on this column results monly available resins combined with gravity flow colin aggregation and precipitation of the protein on the umns can be substituted for FPLC columns. Moreover, column. If binding to Ni-NTA remains problematic, the purification can be performed in a batch method.
change Buffer Z from 8 M urea to 6 M guanidine-HCl Start a 100-to 200-ml LB amp overnight culture (GuHCl) with 10-20 mM imidazole. Because 6 M of highly expressing pTAT-HA-cDNA BL21(DE3)pLysS.
GuHCl is a more stringent denaturant than 8 M urea, The following morning, inoculate the entire volume into the protein becomes further unfolded and exposes the 1 liter of LB amp plus 100-500 M IPTG and shake His 6 purification leader. However, removal of GuHCl for 5 (or up to 10) h at 37ЊC. Isolate and wash the cell requires more steps than the 8 M urea protocol. Thus, pellet in phosphate-buffered saline (PBS), then resuswe routinely use 8 M urea unless otherwise necessary. pend in 10-20 ml of Buffer Z and sonicate on ice 3 ϫ If preparing the fusion protein under soluble condi-15 s pulses. (This sonication step may need further tions, some proteins may precipitate at high concentraoptimization for each sonication system.) Clarify the tions after elution from Ni-NTA. We suggest several sonicate by centrifuging at 16,000g, 4ЊC for 10 min and save the supernatant fraction. Please note that some possibilities to reduce this occurrence. First, centrifuge the eluate as soon as precipitation is noticed. Removal NaCl step in Buffer A. Analyze St, Ft, and eluate fraction by SDS-PAGE as outlined above and pool approof the precipitating nuclei from the solution will reduce a further precipitation cascade. Second, immediate ad-priate fractions. The sample is then desalted on a PD-10 desalting column and analyzed by SDS-PAGE. See dition of glycerol at concentrations of 10-20% (v/v) can also reduce precipitation. Follow with the same concen-PD-10 procedure below.
By reducing the urea from 4 to 0 M in a single step, tration of glycerol into the desalting phase of the procedure in a PD-10 rapid buffer exchange procedure. (see the denatured proteins are forced to become soluble in an aqueous environment. Due to the mixed population next page) of protein configurations and biophysical properties, use of a single 1-2 M NaCl step is preferred to a linear NaCl gradient and will result in a sharper protein peak
SOLUBILIZATION OF DENATURED PURIFIED
resolution and increased concentration.
TAT-FUSION PROTEINS INTO AQUEOUS BUFFER
Troubleshooting. If failure to bind or weak binding of protein is observed, try the other column type regardThe major pitfall experienced when preparing TATless of predicted pI. If strong binding is observed (i.e., fusion proteins is the high occurrence of precipitation no protein present in FT), but no or poor yield in eluate, of the unfolded proteins after placing them into an aqueseveral modifications to reduce the effective avidity of ous environment. To treat tissue culture cells and anithe protein to the resin can be used. As an example, if mal models with TAT-fusion proteins, the denaturant, protein "X" binds the Q resin at 50 mM NaCl, but fails 8 M urea or 6 M GuHCl, must be rapidly removed.
to elute, clean the column with HCl/NaOH (see manuRapid removal of the denaturant achieves the goal of facturer's directions). Equilibrate the sample and colobtaining highly energetic (⌬G) denatured TAT-fusion umn with 100 mM NaCl, inject sample, and elute as proteins that have a higher potential of yielding phenoabove. Check St, FT, and column fractions as outlined typic effects than those prepared under slow folding above on SDS-PAGE. Continue to increase NaCl con-(dialysis) techniques. Several choices for this procedure centration by 50 mM steps until recovery yield is 70-are described below. In our experience, use of Mono Q 90% of input or protein is observed in FT. Alternatively, or S ionic exchange chromatography yields superior decrease (Q resin) or increase (S resin) the pH of Buffer results compared with removal by desalting columns.
A by steps of 0.5 pH unit until a small amount of protein However, we have generated transducible TAT-fusion is detected in the FT fraction. The goal is to decrease proteins by both of these approaches (Fig. 1B) .
to avidity of the protein for the column in urea to the point of obtaining a reversible binding. We have used both of these strategies to isolate several proteins, including injecting samples at 200 mM NaCl/pH 7.0 into Ionic Exchange Chromatography (FPLC) a Mono Q column. In addition, substitution of KCl for Although the purification of most proteins by ionic NaCl may be advantageous for some proteins. exchange chromatography (Q and S resins, AmershamPlease note that due to the ionic nature of GuHCl, if Pharmacia, Uppsala, Sweden) is largely dependent on it was used to denature and purify the TAT-fusion prothe isoeletric point (pI ) of the fusion protein, it has been tein on Ni-NTA it must be placed into 8 M urea on a our experience that TAT-fusion proteins in 4 M urea PD-10 prior to addition to the Q or S resin. will bind to the Mono Q or S resin independently of their predicted pI. Therefore, if the fusion protein of Ion Exchange by Gravity Flow Columns and Batch Preps interest does not bind to the predicted resin, try the other.
Due to the protocol design of using single elution steps, automated FPLC or HPLC is not required. Set For FPLC equipment that is maintained at 4ЊC, avoid crystallization of 8 M urea by diluting the pooled Ni-up a 1-to 5-ml ionic exchange column using 30-micron Resource Q or S resin (Amersham-Pharmacia, Upp-NTA fractions from above, 1:1 with 20 mM Hepes, pH 8.0 for Mono Q and pH 6.5 for Mono S. This will result sala, Sweden). The sample is diluted as above and, due to a low back pressure, is injected into the preequiliin 50 mM NaCl and 4 M urea final concentrations. If the FPLC equipment is maintained at room temperature, brated column via syringe. Wash the column with ϳ50 ml buffer A plus imidazole and elute TAT-fusion protein dilute in Buffer Z with no NaCl to obtain a final 50 mM NaCl. Inject the sample into a 5/5 or 10/10 (preferred) with a single step of 1-2 M NaCl. The sample is then desalted on a PD-10 desalting column, collected, and Mono Q/S column equilibrated in Buffer A plus urea (4 or 8 M depending on temperature). Wash with ϳ20-50 analyzed by SDS-PAGE. Troubleshoot as described above. ml Buffer A (no urea) and elute with a single 1-2 M For batch preps, add 1-5 ml of Resource Q and S the column. One-milliliter fractions are conveniently collected in microcentrifuge tubes. The protein will beresin directly to the 10-20 ml of Ni-NTA eluate and place on a rotator at room temperature or 4ЊC for 15-60 gin eluting in fraction 4. Analyze the ST, and each fraction collected, by SDS-PAGE. Pool the appropriate min. Pellet beads in centrifuge at 2000-4000g for 3-5 min, aspirate the supernant fraction, and wash three fractions. times in 10-20 ml Buffer A. Elute the bound protein
Troubleshooting. The most common problem inby adding 1-10 ml Buffer B and analyze as above. This curred when desalting directly from 8 M urea or 6 M method has the added benefit that by mixing equal GuHCl is protein precipitation on the PD-10 column. amounts of Q and S resin, predetermination of resin This can be alleviated by dilution of the protein or use binding by the protein is not required.
of equilibrated columns in 10-20% glycerol and/or 1% Troubleshooting. For some TAT-fusion proteins, we BSA to help stabilize the protein. In addition, some detect irreversible binding to the Q or S resin, even proteins are more stable when desalted into 10 mM when using increased NaCl or KCl concentrations at Tris-HCl, pH 8.0, 0.1 mM EDTA. the starting equilibrium, at 4ЊC. However, the same protocol preformed at room temperature (20-24ЊC), instead of 4ЊC, can give higher yields.
Storage of the Purified Proteins
Determine the purified protein concentration by Desalting/Buffer Exchange Column (PD-10 Column SDS-PAGE relative to a standard, such as BSA, and/or Procedure)
by protein concentration analysis if the protein appears pure by a Coomassie blue-stained SDS-PAGE. The puThe theory behind rapid desalting is that passage of rified TAT-fusion protein is then flash-frozen in 100-to a denatured protein from 8 M urea or 6 M GuHCl 200-l volumes in 10-20% glycerol and stored at through the interface into PBS forces the protein to Ϫ80ЊC. After freezing, test a vial for loss of protein due rapidly hide its hydrophobic residues and become aqueto freeze-thaw induced precipitation by thawing a vial, ously soluble. PD-10 desalting columns have a 1:1. 4 spinning at 16,000g at 4ЊC for 10 min, and analyzing dilution factor. Therefore, denatured proteins will be by SDS-PAGE. In addition, once a protein aliquot is separated from each other, helping to avoid aggregation thawed, it should never be refrozen. The length of time of the proteins and subsequent precipitation on the cola fusion can be frozen in this manner will be protein and umn. Although we have used this strategy to remove preparation specific. In our hands, frozen TAT-fusion the urea from many TAT-fusion proteins, in general, it proteins, such as TAT-E1A, are capable of retaining also produces protein preps that are more susceptible transduction potential on thawing when stored at to precipitation and freeze-thaw problems. However, Ϫ80ЊC for 2 years! it is a rapid and inexpensive procedure that has proven useful for several proteins.
The PD-10 column is a prepacked Sephadex G-25 M
DETECTION OF PROTEIN TRANSDUCTION
resin that can be used to desalt or buffer exchange a protein preparation and is available from AmershamPharmacia. The column must be drained of its storage The concentration and dosing schedule at which a TAT-fusion protein must be administered in vitro must solution, then preequilibrated with 25 ml of the buffer of choice. We routinely equilibrate the PD-10 one of four be determined experimentally. Generally, it has been our experience that responses can be seen at 100-200 different buffers: sterile PBS; 20 mM Hepes, 100 mM NaCl; 10 mM Tris-HCl, pH 7.5, 1 mM EDTA; or tissue nM. Once a positive (or negative) signal is demonstrated, one can titer accordingly as required with a culture medium without serum. PBS is the preferred buffer when the protein is to be injected into an animal, routine range of concentrations between 10 nM and 1 M. while tissue culture medium without serum is preferred when transducing tissue culture cells. Buffer exchange Protein transduction and localization can be achieved in one of two ways. The first method is by directly into the tissue culture medium allows one to add larger volumes of the fusion protein to the culture medium labeling the fusion protein with fluorescein isothiocynate (FITC, Molecular Probes, Eugene, OR). Once conwith little loss of nutrients due to dilution. Apply no more than 2.4 ml of protein from the Ni-NTA or ion-jugated to the basic residues of the fusion protein, the unconjugated material can be removed, and the labeled exchange columns onto the equilibrated PD-10 column. When the fusion protein has entered the gel bed, add protein added to cells and analyzed by fluorescenceactivated cell sorting (FACS) or direct visualization by more buffer to top out the column. Begin collecting fractions immediately on addition of the fusion protein onto confocal or fluorescent microscopy. A drawback to this method is that its success depends heavily on a good compartments, and an absence of merely perimembrane staining that is observed with free FITC negalabeling reaction. If the reaction is poor, the fluorescence intensity will be too low to detect. tive control.
The second method of visualization of the protein is
Troubleshooting. Keep in mind that protein transthe use of immunocytochemistry. The method uses a duction is a concentration-dependent process. Thereprimary antibody specific for the fusion protein (anti-fore, if the extracellular protein concentration is HA or anti-protein X) and a secondary antibody that is changed, i.e., slowly washing the cells, the intracellular fluorescently labeled. This option is flexible, in that one FITC-labeled TAT-fusion protein will shift the equilibmay choose to colocalize other molecules or compart-rium and can transduce back out of the cells. For FACS ments of the cell with other flourophores such as DAPI this is generally not an issue; however, for fluorescent that will stain nuclei at a different excitation wave-confocal microscopy, this can make a significant differlength.
ence in the ability to detect intracellular FITC-labeled TAT-fusion proteins.
Labeling TAT-Fusion Proteins with Fluorescein (FITC) Visualization of TAT-Fusion Proteins by Twenty to fifty micrograms of TAT-fusion protein is
Immunocytochemistry placed in a 300-l reaction mixture with the appropriate volume of 10X carbonate buffer, per the manufacIntracellular localization of TAT-fusion proteins can also be visualized by immunocytochemistry using fluorturer's instructions, for 2 h at room temperature. The nonconjugated FITC is then removed from the FITC-ophore-conjugated antibodies. An advantage of this method over the use of directly labeled proteins is that labeled TAT protein by either gel filtration chromatography or use of a PD-10 column equilibrated in PBS. it does not rely on transduction of a fluorophore in addition to full-length protein. Furthermore, backWhen the PD-10 column is used, isolate 1-ml column fractions and check each fraction by protein assay and/ ground fluorescence is abrogated with the use of epitope-specific antibodies. Cells are plated at the approor SDS-PAGE. If available, check for efficiency of FITC crosslinking by use of a fluorometer. Poorly labeled TAT-priate density into wells of commercially available glass or tissue culture-treated microscope slides, and allowed fusion proteins will result in a low signal-to-noise ratio. Therefore, if the amount of signal is not satisfactory, to adhere (typically overnight ). Culture medium is then removed from each well using a glass pipet attached to alter the labeling conditions by increasing/decreasing the ratio of protein to FITC in the labeling reaction. a vacuum apparatus. It is important to vacuum the fluid from the same position in each well to minimize To analyze transduction of fluorescently labeled TATfusion protein into cells, add 100-400 l of purified cell disruption. Cells are then incubated with fresh medium containing the specific TAT-fusion protein to be FITC-labeled TAT-fusion protein to 10 5 to 10 6 cells in 0.5-1 ml of medium. Analyze for transduction by flow transduced. At the desired time point following transduction, cells are quickly washed with sterile PBS and cytometry (FACS) analysis 10, 20, and 30 min after addition of the FITC-labeled TAT-fusion protein. In our fixed in 4% paraformaldehyde fix buffer, on ice for 10 min. All reagents throughout the procedure are applied hands, FITC-labeled TAT-fusion proteins rapidly transduced into cells, achieving maximum intracellular con-directly to each chamber well using a transfer pipet, and removed using a clean glass pipet attached to a centrations in less than 5 min. In addition, we note a narrow intracellular concentration range of the trans-vacuum apparatus. If intracellular antigens are to be detected, then cells must be permeabilized with 100% duced protein within the population as supported by the narrow FACS peak width between control and ethanol for 10 min on ice following fixation. Cells are then washed three times with cold PBS. Nonspecific transduced cells.
To analyze transduction of FITC-labeled TAT-fusion epitopes are blocked using the appropriate blocking agent diluted in PBS for 10 min at 42ЊC. Appropriate proteins by fluorescent confocal microscopy, treat cells that have been cultured on a glass coverslip with the blocking agents include serum from the species in which the secondary antibody is generated and a 1% BSA FITC-labeled TAT-fusion protein for 15-60 min, then rapidly wash individual coverslips two or three times solution. Cells are washed three times with cold PBS, and then incubated with the specific primary antibody in PBS buffer and fix in 4% paraformaldehyde fix buffer. Mount the coverslips and view under a fluorescent mi-for 15 min at 42ЊC. After being washed three times in cold PBS, the labeled secondary antibody is incubated croscope. At early time points (less than 2-4 h) where the FITC-labeled TAT-fusion protein is in excess we on cells for 10 min at 42ЊC. At this point, the chamber gasket and adhesive are removed from the slide and see fluorescence in both the nuclear and cytoplasmic cells are rinsed with distilled water. Addition of com-for 6 h at 225 rpm and 37ЊC. The cell suspension was harvested at 5000g for 10 min. The cell pellet was mercially available reagents such as Slowfade (Molecular Probes) that diminish loss of fluorescence are recom-washed with PBS, then resuspended in 20 ml of Buffer Z. The suspension was sonicated with 4 cycles of 15 s mended before the slide is mounted with a coverslip. Specific localization of the TAT-fusion protein can then on and 15 s off at 4ЊC. The lysed suspension was clarified by centrifugation at 16,000g for 10 min at 4ЊC. The be visualized via fluorescence or confocal microscopy.
clarified supernatant fraction was equilibrated with 10 Notes and troubleshooting. Select the primary antimM imidazole and applied to a preequilibrated Ni-NTA body specific for the particular antigen under investigaresin with a 7.5-ml bed volume. The crude extract was tion. Choose appropriate controls such as nonimmune allowed to bind to the resin by gravity flow until the or preimmune sera, based on the species in which the entire extract had been adsorbed. The column was then antibody was generated. The secondary antibody is lawashed with 10 bed volumes of Buffer Z with 10 mM beled with a fluorophore and is selected based on the imidazole. The enriched protein was then eluted by species in which the primary antibody was generated.
stepwise application of 100, 250, and 500 mM imidazole. Fluorescently labeled secondary antibodies to specific TAT-Cdc42 variants eluted in the 100 mM imidazole IgG are commercially available. Antibody concentrafraction (Fig. 1C) . The urea in the purified protein fractions must be optimized to obtain the appropriate titer tion was removed by application onto a PD-10 column for specific epitope recognition while eliminating nonthat was preequilibrated with serum-free culture mespecific binding. It is also very important to wash cells dium containing 10% glycerol. The peak fractions were thoroughly between incubations to eliminate nonspepooled, aliquoted, and stored at Ϫ80ЊC until ready for cific background staining. Background can also be diuse. minished by the addition of 0.1% BSA with the primary and secondary antibody incubations.
Transduction into Primary Diploid Fibroblasts

SPECIFIC METHODS FOR TAT-Cdc42
SiFt's were plated at 2.5 ϫ 10 4 cells/ml in an eightchamber glass slide (Falcon) in Dulbecco's modified EaConstruct Design gle's medium (DMEM), 10% fetal calf serum, 1X Pen/ Human CDC42 V12 (constitutively active) and Strep, overnight at 37ЊC. After the cells had adhered CDC42 N17 (dominant negative) plasmid cDNA was to the glass, they were washed with fresh medium and kindly provided by Channing Der (17). The coding re-then TAT-Cdc42 V12 or TAT-Cdc42 N17 was added to a final gion of each plasmid was polymerase chain reaction concentration of 50 nM. Protein was incubated on the (PCR) amplified with the following primers: 5Ј-CGCC cells for 10 min at 37ЊC, then washed two times with GCGCCATGGGCGGCGGCATGCAGACAATTAAGT PBS. Cells were fixed with 4% paraformaldehyde pre-GTGTTGTTGTGGGC-3Ј, and 5Ј-CGCCGCGAATTCT pared freshly in PBS, for 10 min on ice. After three CATAGCAGCACACACCTGCGGC-3Ј. These primers washes with PBS, cells were permeabilized with 100% added the NcoI and EcoRI restriction enzyme sites at EtOH for 10 min on ice and washed three more times. the N and C termini, respectively. The amplimer iden-The cells were stained with 200 ng/ml TRITC-conjutity was confirmed by restriction digest, then cloned gated phalloidin (Sigma Chemical Co., St. Louis, MO) into pTAT-HA using the same restriction sites. After for 1 h at room temperature in the dark. The gasket standard screening methods, the DNA sequence was was then removed, and the slide washed in distilled confirmed with a BigDye DNA sequencing kit (ABI, H 2 O and mounted with Slowfade reagent with a glass Foster City, CA). cover slip.
Protein Production and Isolation Microscopy Plasmid DNA was transformed into BL-21 (DE3)-pLysS E. coli and screened for maximal protein produc-TRITC-labeled F-actin was detected on a Nikon Diaphot 300 microscope with an epifluorescence attachtion and protein identity by Western blotting using the anti-HA antibody (Berkley Antibody Co.). The highest-ment using the 546-nm filter (Fig. 2) . Images were obtained digitally under the 100X objective with a SpotRT producing clone was inoculated into a 200-ml culture of LB plus 50 g/ml ampicillin and incubated overnight camera (Diagnostic Instruments, Inc., St. Louis, MO).
Images were analyzed and represented using Adobe at 225 rpm and 37ЊC for at least 16 h. The inoculum was placed into 1 liter of LB/ampicillin and incubated Photoshop software.
preponderance of forming inclusion bodies in the bacte-DISCUSSION ria is high and regaining solubility can be time consuming. Use of other affinity domains to enrich for the overThis report has described and demonstrated the util-expressed proteins, such as maltose-binding protein ity of TAT-fusion proteins. The reliance on time-consum-and glutathione, has not yet been tried. Additionally, ing and low-efficiency transfection of DNA constructs optimal transduction conditions must be determined is minimized. Nearly uniform distribution of the fusion independently. Each fusion protein will have a different protein within a culture is easily achievable, reducing half-life in serum under in vitro conditions. Therefore, the "background" unaffected cells normally seen in clas-if the expected phenotypic change is not observed, sic transfection experiments. Protein transduction can checking for the degradation of the fusion protein at also reduce the need for laborious microinjection of mol-various time points may be warranted. It may be also ecules into individual cells. Once unattainable tight necessary to apply the fusion protein multiple times in a kinetics of activation cascades can be elucidated with-given time frame to overcome such difficulties. Another out the reliance on the synthesis or degradation of anti-critical parameter is the careful design of the protein. biotics. Consequently, experiments seeking to under-If the native protein is known to be tightly associated at the N terminus, the TAT domain may be buried and stand the kinetics of certain molecules, in certain transduce poorly. Therefore it may be necessary to pathways, are now resolvable in almost real time. The change the spacing at the N terminus while mainexogenous addition of effector molecule at specific time taining the native conformation or consider conpoints within an experiment is achievable neither by structing a C-terminal TAT fusion. transfection methods nor by use of the transfected VP-
The obvious advantages of the system outweigh the 22 transduction domain that "feeds" proteins to surdisadvantages. We have successfully used the procerounding cells.
dure described here to generate and transduce more There are some drawbacks and critical parameters of than 60 TAT-fusion proteins ranging from 15 to 120 the TAT transduction system that should be considered.
kDa into all cells assayed thus far, including primary One of the primary caveats of the system is the of solucells, transformed cells, and tissues present in mice. bility of the fusions. Purification of the fusion proteins Moreover, treatment of cells with TAT-Cdc42 V12 protein in this method relies on the His 6 domain. While this (constitutively active) results in the formation of filodomain is advantageous because of its small size, the podia in less than 10 min (Fig. 2) , while the protein prepared in the same way but harboring a dominant negative mutation yielded no filopodia. These results are consistent with those reported by Nobes and Hall (18, 19) who obtained this phenotype within 12 min of microinjecting Cdc42 V12 into Swiss 3T3 cells. Our observation demonstrates that TAT can deliver functional protein with rapid kinetics of signal transduction. The fusion proteins tested have been shown to transduce into all primary cells that are normally highly resistant to other forms of manipulation to dissect both biological and in vivo biochemical processes. At this time, within our limited understanding of the mechanism of protein transduction (15) , there appears to be no limit to the size of protein that can be transduced. Fusion proteins as small as 20 kDa easily transduce and are almost immediately biologically active, while proteins as high as 120 kDa transduce and are biologically active within 5 min (14).
The use of a genetic in-frame fusion combined with denaturation of the proteins achieves several goals, including isolation of the bulk of recombinant proteins to be rapidly refolded by chaperones (8), such as HSP90 (9) , and are capable of binding their cognate intraFluorescence-activated cell sorter (FACS) Fluorescence microscope (preferably confocal) cellular targets and performing biochemical functions, such as cell cycle arrest, cell migration, cytoskeletal rearrangement, protection from and induction of apoptosis, transcriptional inhibition and activation, REFERENCES and various enzymatic activities (7, (10) (11) (12) (13) (14) (15) . Indeed, every TAT-wild type fusion protein we have generated
